Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongchang Qu

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Diabetes, Obesity & Metabolism|January 21, 2026
Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of conceptShobha Bhattachar, Lai San Tham, Beth Tidemann-Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone lossShuang Liang, Jennifer L Krauss, Hisanori Domon, et al.
Molecular Vision|May 5, 2011
A complement receptor C5a antagonist regulates epithelial to mesenchymal transition and crystallin expression after lens cataract surgery in miceRinako Suetsugu-Maki, Nobuyasu Maki, Timothy P Fox, et al.
Biomaterials|November 10, 2012
Autoregulation of thromboinflammation on biomaterial surfaces by a multicomponent therapeutic coatingPer H Nilsson, Kristina N Ekdahl, Peetra U Magnusson, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 17, 2011
C5aR-antagonist significantly reduces the deleterious effect of a blunt chest trauma on fracture healingStefan Recknagel, Ronny Bindl, Julian Kurz, et al.
Immunobiology|July 17, 2012
New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic propertiesHongchang Qu, Daniel Ricklin, Hongjun Bai, et al.
Blood|April 29, 2010
Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosisIoannis Kourtzelis, Maciej M Markiewski, Michael Doumas, et al.
Atherosclerosis|April 4, 2023
Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP miceRobin van Eenige, Zhixiong Ying, Naomi Tramper, et al.
Ebiomedicine|June 28, 2023
Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP miceZhixiong Ying, Robin van Eenige, Xiaoke Ge, et al.
Molecular Pharmaceutics|January 2, 2023
<i>In Vivo</i> Mechanism of Action of Sodium Caprate for Improving the Intestinal Absorption of a GLP1/GIP Coagonist PeptideHuyen Tran, Eitaro Aihara, Faiz Ahmad Mohammed, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Diabetes, Obesity & Metabolism|January 21, 2026
Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of conceptShobha Bhattachar, Lai San Tham, Beth Tidemann-Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone lossShuang Liang, Jennifer L Krauss, Hisanori Domon, et al.
Molecular Vision|May 5, 2011
A complement receptor C5a antagonist regulates epithelial to mesenchymal transition and crystallin expression after lens cataract surgery in miceRinako Suetsugu-Maki, Nobuyasu Maki, Timothy P Fox, et al.
Biomaterials|November 10, 2012
Autoregulation of thromboinflammation on biomaterial surfaces by a multicomponent therapeutic coatingPer H Nilsson, Kristina N Ekdahl, Peetra U Magnusson, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 17, 2011
C5aR-antagonist significantly reduces the deleterious effect of a blunt chest trauma on fracture healingStefan Recknagel, Ronny Bindl, Julian Kurz, et al.
Immunobiology|July 17, 2012
New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic propertiesHongchang Qu, Daniel Ricklin, Hongjun Bai, et al.
Blood|April 29, 2010
Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosisIoannis Kourtzelis, Maciej M Markiewski, Michael Doumas, et al.
Atherosclerosis|April 4, 2023
Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP miceRobin van Eenige, Zhixiong Ying, Naomi Tramper, et al.
Ebiomedicine|June 28, 2023
Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP miceZhixiong Ying, Robin van Eenige, Xiaoke Ge, et al.
Molecular Pharmaceutics|January 2, 2023
<i>In Vivo</i> Mechanism of Action of Sodium Caprate for Improving the Intestinal Absorption of a GLP1/GIP Coagonist PeptideHuyen Tran, Eitaro Aihara, Faiz Ahmad Mohammed, et al.
Pageof 4